COR: Specialty and oncology growth, stable guidance, and innovation drive strong performance
Specialty pharmaceuticals and oncology drive strong growth, with international and MSO segments performing well. Guidance incorporates minor Walgreens volume shifts, and biosimilars and innovation offer ongoing tailwinds. AI and operational improvements are key focus areas.Based on Cencora, Inc. [C…